What is the risk of intracranial bleeding during anti-VEGF therapy?

Por Carden, Craig P., Larkin, James M.G., Rosenthal, Mark A.
Publicado em 2008

Ovarian cancer stem cell like side populations are enriched following chemotherapy and overexpress EZH2

Por Rizzo, Siân, Hersey, Jenny M., Mellor, Paul, Dai, Wei, Santos-Silva, Alessandra, Liber, Daniel, Luk, Louisa, Titley, Ian, Carden, Craig P, Box, Garry, Hudson, David L., Kaye, Stanley B., Brown, Robert
Publicado em 2011

The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer

Por Carden, Craig P., Stewart, Adam, Thavasu, Parames, Kipps, Emma, Pope, Lorna, Crespo, Mateus, Miranda, Susana, Attard, Gerhardt, Garrett, Michelle D., Clarke, Paul A., Workman, Paul, de Bono, Johann S., Gore, Martin, Kaye, Stan B, Banerji, Udai
Publicado no Mol Cancer Ther (2012)